Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
The Food and Drug Administration recently approved Ahead 300, a handheld medical device that helps clinicians diagnose a traumatic brain injury.
When Mylan CEO Heather Bresch testified before the House Oversight Committee Sept. 21, she told lawmakers the company makes $100 in profit off a two-pack of EpiPens listed at $608. However, Ms. Bresch failed to indicate this number was estimated…
After VanMoof realized its high-end bikes kept getting damaged when shipped to customers, the Amsterdam-based bicycle manufacturer came up with a simple fix: print an image of a flat screen TV on the side of their boxes.
The Food and Drug Administration approved expanded treatment uses for the anti-inflammatory drug llaris, developed by Basel, Switzerland-based Novartis.
Pfizer said it will not split into two publicly traded companies — one for brand name drugs and one for generics — after finding the move would not benefit shareholders, reported Reuters.
The Healthcare Distribution Alliance elected Jon Giacomin chairman of its board of directors.
The Food and Drug Administration Friday approved Amjevita, a biosimilar copy of Abbvie's best-selling arthritis drug Humira.
The Food and Drug Administration granted priority review status to dupilumab, an injectable antibody drug used to treat atopic dermatitis, or eczema.
The Food and Drug Administration granted emergency use authorization for a new Zika diagnostic test developed by Singapore-based Vela Diagnostics.
Intermountain Healthcare's supply chain organization recognized four of its suppliers for their exceptional contributions to the Salt Lake City-based health system's cost, quality and patient outcomes.